A Multicenter Study to Evaluate the Efficacy of a 91-Day Extended Cycle Oral Contraceptive for Menstrually-Related Migraine Headaches

NCT00781456 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

109

Enrollment

INDUSTRY

Sponsor class

Conditions

Migraine

Interventions

DRUG: 91-day Levonorgestrel Oral Contraceptive
DRUG: Placebo

Sponsor

Duramed Research